1. J.M. Anderson and K.K. Marchant, Platelet interaction with biomaterials and artificial devices, CRC Critical Review in Biocompatibility, 1: 111–204 (1985).
2. N. Yui, Y. Sakurai, and K. Kataoka, Microdomain-structured polymers as antithrombogenic materials, in: “Artificial Heart 1,” T. Akutsu, H. Koyanagi, D.G. Pennington, V.L. Poirier, S. Takatani, and K. Kataoka, ed., Springer Verlag, Tokyo (1986).
3. N. Yui, J. Tanaka, K. Sanui, N. Ogata, K. Kataoka, T. Okano, and Y. Sakurai, Effect of crystallinity of polymeric materials on antithrombogenicity, Jpn. J. Artif. Organs, 10: 1070–1073 (1981).
4. N. Yui, J. Tanaka, K. Sanui, and N. Ogata, Polyether-segmented polyamides as a new designed antithrombogenic material: Microstructure of poly(propylene oxide) segmented nylon 610, Makromol. Chem., 185: 2259–2267 (1984).
5. N. Yui, J. Tanaka, K. Sanui, N. Ogata, K. Kataoka, T. Okano, and Y. Sakurai, Characterization of the microstructure of poly(propylene oxide) segmented polyamide and its suppression of platelet adhesion, Polym. J., 16: 119–128(1984).